Issue navigation
Volume 79, Issue 5, May 2024
Viewpoint
Not surprising: a rebound in antibacterial consumption in Europe, with Cyprus and Greece on the podium
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 933–934, https://doi.org/10.1093/jac/dkae055
Systematic Reviews
The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 935–945, https://doi.org/10.1093/jac/dkae045
What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 946–958, https://doi.org/10.1093/jac/dkae058
Virtual Roundtable
Community-acquired pneumonia: a US perspective on the guideline gap
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 959–961, https://doi.org/10.1093/jac/dkae050
Original Research
Genomics to detect transmission of livestock-associated methicillin-resistant Staphylococcus aureus from UK pigs in abattoirs during slaughter
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 962–967, https://doi.org/10.1093/jac/dkae052
Corynebacterium diphtheriae and Corynebacterium ulcerans: development of EUCAST methods and generation of data on which to determine breakpoints
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 968–976, https://doi.org/10.1093/jac/dkae056
Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin- or multidrug-resistant tuberculosis in Indonesia
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 977–986, https://doi.org/10.1093/jac/dkae057
PHARE: a bioinformatics pipeline for compositional profiling of multiclonal Plasmodium falciparum infections from long-read Nanopore sequencing data
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 987–996, https://doi.org/10.1093/jac/dkae060
Development of an ultrafast PCR to detect clinically relevant acquired vancomycin-resistance genes from cultured enterococci
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 997–1005, https://doi.org/10.1093/jac/dkae062
Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125–1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1006–1013, https://doi.org/10.1093/jac/dkae063
Aminoglycoside resistance genes in early members of the Acinetobacter baumannii ST78A (SMAL, Italian clone) reside in an IS26-bounded island in the chromosome
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1014–1018, https://doi.org/10.1093/jac/dkae064
Assessment of risk-adjusted mortality ratio (RAMR) in bloodstream infections using all-patient refined diagnosis-related groups (APR-DRGs)
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1019–1022, https://doi.org/10.1093/jac/dkae065
Novel tetracycline resistance gene tet(65) located on a multi-resistance Corynebacterium plasmid
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1023–1029, https://doi.org/10.1093/jac/dkae066
VIM-type metallo-β-lactamase (MBL)-encoding genomic islands in Pseudomonas spp. in Poland: predominance of clc-like integrative and conjugative elements (ICEs)
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1030–1037, https://doi.org/10.1093/jac/dkae068
Empirical antimicrobial prescribing for pyelonephritis in patients discharged from 15 US Emergency Departments: an opportunity for improvement
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1038–1044, https://doi.org/10.1093/jac/dkae070
Comparison of the in vitro activities of delafloxacin and comparators against Staphylococcus epidermidis clinical strains involved in osteoarticular infections: a CRIOGO multicentre retrospective study
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1045–1050, https://doi.org/10.1093/jac/dkae071
Impact of the phenotypic expression of temocillin resistance in Escherichia coli on temocillin efficacy in a murine peritonitis model
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1051–1059, https://doi.org/10.1093/jac/dkae072
Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016–20
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1060–1068, https://doi.org/10.1093/jac/dkae073
Synergistic effects of ceftazidime/avibactam combined with meropenem in a murine model of infection with KPC-producing Klebsiella pneumoniae
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1069–1080, https://doi.org/10.1093/jac/dkae074
Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017–20 compared to 2015–16
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1081–1092, https://doi.org/10.1093/jac/dkae075
Towards optimizing cefepime/tazobactam (WCK 4282) exposure to achieve efficacy against piperacillin/tazobactam-resistant ESBL infections: dose recommendations for various renal functions, including intermittent haemodialysis, in healthy individuals
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1093–1100, https://doi.org/10.1093/jac/dkae076
In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1101–1108, https://doi.org/10.1093/jac/dkae077
Effect of methenamine hippurate shortage on antibiotic prescribing for urinary tract infections in Norway—an interrupted time series analysis
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1109–1117, https://doi.org/10.1093/jac/dkae078
Imipenem/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenation
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1118–1125, https://doi.org/10.1093/jac/dkae079
Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1126–1132, https://doi.org/10.1093/jac/dkae080
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1133–1141, https://doi.org/10.1093/jac/dkae083
Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1142–1152, https://doi.org/10.1093/jac/dkae084
Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1153–1156, https://doi.org/10.1093/jac/dkae085
Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1157–1163, https://doi.org/10.1093/jac/dkae086
Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1164–1168, https://doi.org/10.1093/jac/dkae087
Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1169–1175, https://doi.org/10.1093/jac/dkae088
Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1176–1181, https://doi.org/10.1093/jac/dkae089
Ceftazidime/avibactam serum concentration in patients on ECMO
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1182–1186, https://doi.org/10.1093/jac/dkae091
Influence of ultrafiltration conditions on the measurement of unbound drug concentrations: flucloxacillin as an example
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1187–1190, https://doi.org/10.1093/jac/dkae092
Research Letters
Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1191–1192, https://doi.org/10.1093/jac/dkae038
Early virological failure with cabotegravir/rilpivirine
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1193–1194, https://doi.org/10.1093/jac/dkae044
Comparison of the French novel disc diffusion-based algorithm and the current EUCAST guidelines for the screening of carbapenemase-producing Enterobacterales
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1194–1196, https://doi.org/10.1093/jac/dkae054
Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 1196–1200, https://doi.org/10.1093/jac/dkae082
Correction
Correction to: Pharmacokinetic modelling to predict risk of ototoxicity with intravenous tobramycin treatment in cystic fibrosis
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Page 1201, https://doi.org/10.1093/jac/dkae069
